Vimarsana
Biggest News Aggregation in the World

Page 3 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hal Barron Today - Breaking & Trending Today

GSK (LON:GSK) Receives Buy Rating from Deutsche Bank Aktiengesellschaft - Vimarsana News

GSK (LON:GSK) Receives Buy Rating from Deutsche Bank Aktiengesellschaft

GSK (LON:GSK – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Deutsche Bank Aktiengesellschaft in a research note issued on Tuesday, Digital Look reports. Other equities research analysts have also issued reports about the stock. Morgan Stanley upped their price target on shares of GSK from GBX 1,440 ($17.41) to […]

GSK plc (LON:GSK) Receives Consensus Rating of "Hold" from Brokerages - Vimarsana News

GSK plc (LON:GSK) Receives Consensus Rating of "Hold" from Brokerages

GSK plc (LON:GSK – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eight research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and three have issued a buy recommendation on the company. […]

JPMorgan Chase & Co. Reaffirms "Underweight" Rating for GSK (LON:GSK) - Vimarsana News

JPMorgan Chase & Co. Reaffirms "Underweight" Rating for GSK (LON:GSK)

JPMorgan Chase & Co. restated their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note published on Friday morning, MarketBeat.com reports. Several other analysts have also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a buy rating and set a GBX 1,700 ($20.76) target price on shares of […]

GSK (LON:GSK) Earns "Underweight" Rating from JPMorgan Chase & Co. - Vimarsana News

GSK (LON:GSK) Earns "Underweight" Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their underweight rating on shares of GSK (LON:GSK – Free Report) in a research note released on Friday morning, MarketBeat reports. A number of other brokerages have also recently weighed in on GSK. Shore Capital restated a buy rating on shares of GSK in a research note on Friday, June […]

Source: wkrb13.com
GSK's (GSK) Underweight Rating Reaffirmed at JPMorgan Chase & Co. - Vimarsana News

GSK's (GSK) Underweight Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their underweight rating on shares of GSK (LON:GSK – Free Report) in a research report released on Friday, Marketbeat Ratings reports. A number of other equities analysts also recently commented on GSK. Shore Capital reissued a buy rating on shares of GSK in a research note on Friday, June 16th. […]